211 related articles for article (PubMed ID: 28661974)
41. Antibacterial creams for the treatment of burns in infants and toddlers.
Kudlácková M
Acta Chir Plast; 1988; 30(1):39-43. PubMed ID: 2455403
[No Abstract] [Full Text] [Related]
42. Comparative study of Silver Sulfadiazine with other materials for healing and infection prevention in burns: A systematic review and meta-analysis.
Nímia HH; Carvalho VF; Isaac C; Souza FÁ; Gemperli R; Paggiaro AO
Burns; 2019 Mar; 45(2):282-292. PubMed ID: 29903603
[TBL] [Abstract][Full Text] [Related]
43. A review of the dosimetry of 1% silver sulfadiazine cream in burn wound treatment.
Fuller FW; Parrish M; Nance FC
J Burn Care Rehabil; 1994; 15(3):213-23. PubMed ID: 8056810
[TBL] [Abstract][Full Text] [Related]
44. Comparison of purified olive oil and silver sulfadiazine in the treatment of partial thickness porcine burns.
Gurfinkel R; Palivatkel-Naim M; Gleisinger R; Rosenberg L; Singer AJ
Am J Emerg Med; 2012 Jan; 30(1):79-83. PubMed ID: 21159471
[TBL] [Abstract][Full Text] [Related]
45. Randomized Controlled Trial of Polyhexanide/Betaine Gel Versus Silver Sulfadiazine for Partial-Thickness Burn Treatment.
Wattanaploy S; Chinaroonchai K; Namviriyachote N; Muangman P
Int J Low Extrem Wounds; 2017 Mar; 16(1):45-50. PubMed ID: 28682677
[TBL] [Abstract][Full Text] [Related]
46. The novel antibacterial drug XF-70 is a potent inhibitor of Staphylococcus aureus infection of the burn wound.
Hurtuk MG; He LK; Szilagyi A; Gamelli RL; Hecht DW; Kennedy RH; Rhys-Williams W; Love WG; Shankar R
J Burn Care Res; 2010; 31(3):462-9. PubMed ID: 20453736
[TBL] [Abstract][Full Text] [Related]
47. [Experimental animal studies of the healing of burn wounds with the use of local antimicrobials and hyperbaric O2 therapy].
Kaiser W
Z Exp Chir Transplant Kunstliche Organe; 1989; 22(1):27-37. PubMed ID: 2711716
[TBL] [Abstract][Full Text] [Related]
48. Comparison of topical zinc oxide and silver sulfadiazine in burn wounds: an experimental study.
Arslan K; Karahan O; Okuş A; Unlü Y; Eryılmaz MA; Ay S; Sevinç B
Ulus Travma Acil Cerrahi Derg; 2012 Sep; 18(5):376-83. PubMed ID: 23188597
[TBL] [Abstract][Full Text] [Related]
49. Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds.
Shanmugasundaram N; Uma TS; Ramyaa Lakshmi TS; Babu M
J Biomed Mater Res A; 2009 May; 89(2):472-82. PubMed ID: 18431769
[TBL] [Abstract][Full Text] [Related]
50. Results of a multicenter outpatient burn study on the safety and efficacy of Dimac-SSD, a new delivery system for silver sulfadiazine.
Deitch EA; Sittig K; Heimbach D; Jordan M; Cruse W; Kahn A; Achauer B; Finley R; Matsuda T; Salisbury R
J Trauma; 1989 Apr; 29(4):430-4. PubMed ID: 2651681
[TBL] [Abstract][Full Text] [Related]
51. Nonsilver treatment vs. silver sulfadiazine in treatment of partial-thickness burn wounds in children: a systematic review and meta-analysis.
Rashaan ZM; Krijnen P; Klamer RR; Schipper IB; Dekkers OM; Breederveld RS
Wound Repair Regen; 2014; 22(4):473-82. PubMed ID: 24899251
[TBL] [Abstract][Full Text] [Related]
52. Liposome-encapsulated silver sulfadiazine (SSD) for the topical treatment of infected burns: thermodynamics of drug encapsulation and kinetics of drug release.
Lichtenstein A; Margalit R
J Inorg Biochem; 1995 Nov; 60(3):187-98. PubMed ID: 8586972
[TBL] [Abstract][Full Text] [Related]
53. Honey-based Silver Sulfadiazine Microsponge-Loaded Hydrogel:
Patel P; Thanki A; Viradia D; Shah P
Curr Drug Deliv; 2023; 20(5):608-628. PubMed ID: 35578874
[TBL] [Abstract][Full Text] [Related]
54. Sildimac: a new delivery system for silver sulfadiazine in the treatment of full-thickness burn injuries.
Miller L; Hansbrough J; Slater H; Goldfarb IW; Kealey P; Saffle J; Kravitz M; Silverstein P
J Burn Care Rehabil; 1990; 11(1):35-41. PubMed ID: 2179222
[TBL] [Abstract][Full Text] [Related]
55. [Effect of silver nanoparticle dressing on second degree burn wound].
Chen J; Han CM; Lin XW; Tang ZJ; Su SJ
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):50-2. PubMed ID: 16620649
[TBL] [Abstract][Full Text] [Related]
56. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
[TBL] [Abstract][Full Text] [Related]
57. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds.
Acikel C; Oncul O; Ulkur E; Bayram I; Celikoz B; Cavuslu S
J Burn Care Rehabil; 2003; 24(1):37-41. PubMed ID: 12543989
[TBL] [Abstract][Full Text] [Related]
58. Investigation of acute effects of Hypericum perforatum (St. John's Wort-Kantaron) treatment in experimental thermal burns and comparison with silver sulfadiazine treatment.
Kıyan S; Uyanıkgil Y; Altuncı YA; Çavuşoğlu T; Çetin Uyanıkgil EÖ; Karabey F
Ulus Travma Acil Cerrahi Derg; 2015 Sep; 21(5):323-36. PubMed ID: 26388268
[TBL] [Abstract][Full Text] [Related]
59. Assessing effect of three herbal medicines in second and third degree burns in rats and comparison with silver sulfadiazine ointment.
Akhoondinasab MR; Khodarahmi A; Akhoondinasab M; Saberi M; Iranpour M
Burns; 2015 Feb; 41(1):125-31. PubMed ID: 24907191
[TBL] [Abstract][Full Text] [Related]
60. Trends in anti-infective treatment of burn patients: a 3-year retrospective review.
Knolle P
Burns Incl Therm Inj; 1984 Oct; 11(1):54-8. PubMed ID: 6509352
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
